血浆前激肽释放酶寡核苷酸反义疗法对凝血和纤溶检测的影响：一项事后分析 - Suppr

The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis.

作者信息

Fijen Lauré M, Petersen Remy S, Meijers Joost C M, Bordone Laura, Levi Marcel, Cohn Danny M

机构信息

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Thromb Haemost. 2022 Dec;122(12):2045-2049. doi: 10.1055/a-1926-2367. Epub 2022 Aug 17.

DOI:10.1055/a-1926-2367

PMID:35977698

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9718591/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8baf/9718591/3457e5c4a827/10-1055-a-1926-2367-i22040202-1.jpg

相似文献

The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis.血浆前激肽释放酶寡核苷酸反义疗法对凝血和纤溶检测的影响：一项事后分析

Thromb Haemost. 2022 Dec;122(12):2045-2049. doi: 10.1055/a-1926-2367. Epub 2022 Aug 17.

ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.可逆性纤溶酶抑制剂对纤溶作用的增强及抗纤溶酶的拮抗作用

Life Sci (1962). 1965 Jan;4:45-51. doi: 10.1016/0024-3205(65)90031-7.

[NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].[生理抗凝系统保护反应过程中血液中抗纤溶酶的中和作用]

Probl Gematol Pereliv Krovi. 1964 Apr;9:12-5.

Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system.遗传性血管性水肿中纤溶酶-α2-抗纤溶酶复合物水平升高：内源性纤溶系统体内效能的证据。

Thromb Res. 1985 Dec 15;40(6):817-21. doi: 10.1016/0049-3848(85)90318-4.

[Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].[接触（前激肽释放酶）和纤溶（纤溶酶原/抗纤溶酶值）系统在糖尿病血管并发症的病理生理学中的作用]

J Mal Vasc. 1982;7(3):221-4.

Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.儿童心脏直视手术期间及术后纤维蛋白溶解、凝血和血浆激肽释放酶-激肽系统的激活。

Scand J Clin Lab Invest. 1995 Jul;55(4):359-67. doi: 10.3109/00365519509104974.

Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.妊娠中毒症中的凝血-纤维蛋白溶解系统和激肽形成系统。

Gynecol Obstet Invest. 1988;26(3):181-90. doi: 10.1159/000293693.

[ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].[论机体中的防御性反射抗纤溶酶系统]

Biull Eksp Biol Med. 1963 Sep;56:29-33.

On the interaction between dextran and the primary fibrinolysis inhibitor alpha 2-antiplasmin.关于右旋糖酐与原发性纤溶抑制剂α2-抗纤溶酶之间的相互作用

Thromb Res. 1980;19(1-2):103-10. doi: 10.1016/0049-3848(80)90408-9.

Surface activation of blood coagulation, fibrinolysis and kinin formation.血液凝固、纤维蛋白溶解和激肽形成的表面激活。

Nature. 1980 Jul 31;286(5772):456-60. doi: 10.1038/286456a0.

引用本文的文献

Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.遗传性血管性水肿：过度接触激活的临床表现。

Semin Thromb Hemost. 2024 Oct;50(7):978-988. doi: 10.1055/s-0042-1758820. Epub 2022 Nov 23.

本文引用的文献

Inhibition of Prekallikrein for Hereditary Angioedema.抑制激肽原酶治疗遗传性血管性水肿。

N Engl J Med. 2022 Mar 17;386(11):1026-1033. doi: 10.1056/NEJMoa2109329.

Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.C1酯酶抑制剂正常的遗传性血管性水肿患者的临床特征及治疗结果

World Allergy Organ J. 2022 Jan 27;15(1):100621. doi: 10.1016/j.waojou.2021.100621. eCollection 2022 Jan.

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.血液凝固与 I 型和 II 型遗传性血管性水肿的发病机制。

Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6.

Coagulation factor XII, XI, and VIII activity levels and secondary events after first ischemic stroke.首次缺血性卒中后凝血因子 XII、XI 和 VIII 的活性水平及继发事件

J Thromb Haemost. 2020 Dec;18(12):3316-3324. doi: 10.1111/jth.15092. Epub 2020 Oct 15.

Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence.严重血浆前激肽释放酶缺乏症：临床特征、新型KLKB1突变及估计患病率

J Thromb Haemost. 2020 Jul;18(7):1598-1617. doi: 10.1111/jth.14805. Epub 2020 May 15.

Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports.遗传性高分子量激肽原缺乏症（Fletcher 因子缺乏症）的长期安全性结局：病例报告的系统文献回顾。

Allergy Asthma Proc. 2020 Jan 17;41(1):10-18. doi: 10.2500/aap.2020.41.190005.

Prolonged activated partial thromboplastin time due to plasma prekallikrein deficiency: a case study and literature review on its clinical significance.血浆前激肽释放酶缺乏导致活化部分凝血活酶时间延长：一项病例研究及其临床意义的文献综述

Blood Coagul Fibrinolysis. 2019 Sep;30(6):300-303. doi: 10.1097/MBC.0000000000000837.

Cardiovascular diseases in congenital prekallikrein deficiency: comparison with other chance-associated morbidities.先天性前激肽释放酶缺乏症中的心血管疾病：与其他偶发性相关疾病的比较。

Blood Coagul Fibrinolysis. 2018 Jul;29(5):423-428. doi: 10.1097/MBC.0000000000000735.

Plasma Prekallikrein: Its Role in Hereditary Angioedema and Health and Disease.血浆前激肽释放酶：其在遗传性血管性水肿以及健康与疾病中的作用

Front Med (Lausanne). 2018 Jan 25;5:3. doi: 10.3389/fmed.2018.00003. eCollection 2018.

Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.Klkb1-/- 小鼠的血栓形成减少是由 Mas 受体、前列环素、Sirt1、KLF4 增加和组织因子减少介导的。

Blood. 2015 Jan 22;125(4):710-9. doi: 10.1182/blood-2014-01-550285. Epub 2014 Oct 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献